Global Neonatal Respiratory Distress Syndrome Treatment Market
HealthcareServices

Neonatal Respiratory Distress Syndrome Treatment Market Trends Report 2025 – For Business Development and Strategy Teams

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Neonatal Respiratory Distress Syndrome Treatment Market Growth in 2025?

In the past few years, the neonatal respiratory distress syndrome treatment market has seen substantial growth. It is anticipated to rise from $0.96 billion in 2024 to $1.03 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. Factors contributing to this growth during the historical period include enhanced permeability and fluid build-up within the alveoli, an increase in alveolar-capillary permeability, increased use of mechanical ventilation, heightened awareness of neonatal care importance among healthcare providers and parents, as well as greater investments in healthcare.

What Is the Forecast for the Neonatal Respiratory Distress Syndrome Treatment Market Size Through 2029?

Anticipations are set for a robust expansion in the neonatal respiratory distress syndrome treatment market in the upcoming years. The predicted growth places it at $1.41 billion by 2029, with a compound annual growth rate (CAGR) of 8.0%. Increased attraction towards accessories and consumables, an upswing in NICU admissions, growing demand for personalised medicine, rising instances of premature birth, and an upturn in research and development initiatives are all contributing factors for the growth projected in this period. Key trends foresee an increase in automation within neonatal intensive care units (NICUs), artificial intelligence (AI) integration, progresses in neonatal care technology, surfactant therapy advances, and evolution in ventilator technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20899&type=smp

What are the Key Market Players in Neonatal Respiratory Distress Syndrome Treatment Market and How They’re Evolving?

Major companies operating in the neonatal respiratory distress syndrome treatment market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic Plc, Medline Industries, Becton Dickinson, Stryker Corporation, GE Healthcare, Koninklijke Philips NV, ResMed Inc., Drägerwerk AG & Co. KGaA, Chiesi Farmaceutici, ICU Medical Inc., Fisher & Paykel Healthcare, Vyaire Medical, Laerdal Medical, Hamilton Medical, Inspiration Healthcare, Ventec Life Systems, Neotech Products, Aerogen Pharma Corp., Windtree Therapeutics Inc., Discovery Laboratories Inc., Lyomark Pharma GmbH

What Are the Primary Growth Drivers in the Neonatal Respiratory Distress Syndrome Treatment Market?

The increase in premature births is expected to stimulate growth in the neonatal respiratory distress syndrome treatment market. A premature birth, or preterm birth, occurs when a baby is born before the 37th week of pregnancy. Babies born prior to the 32nd week are at the highest risk due to their underdeveloped lungs and insufficient production of surfactant. The incidence of premature births is on the rise due to factors including advanced maternal age, multiple pregnancies, existing health problems, lifestyle choices, use of fertility treatments, infections, and environmental influences. Neonatal respiratory distress syndrome (NRDS) treatment is often necessary for these premature babies, as it aids in improving lung function, stabilizing breaths, and minimizing the threat of respiratory failure. For example, Tommy’s, a charity organization based in the UK, reported in December 2022 that the percentage of live premature births in England and Wales rose from 7.5% in 2021 to 7.9% in 2022, marking the second successive year of growth in premature births. Over 53,000 babies were born prematurely in 2022 as a result. Therefore, the escalating incidence of premature births is fueling the growth of the neonatal respiratory distress syndrome treatment market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20899&type=smp

What Are the Leading Segments in the Global Neonatal Respiratory Distress Syndrome Treatment Industry?

The neonatal respiratory distress syndrome treatment market covered in this report is segmented –

1) By Therapy: Oxygen Therapy, Surfactant Therapy

2) By Route Of Administration: Parenteral, Inhalation, Other Routes Of Administration

3) By End User: Hospitals, Sub-Acute Facilities, Home Care, Retail Pharmacies

Subsegments:

1) By Oxygen Therapy: Conventional Oxygen Therapy, High-Flow Nasal Cannula (HFNC) Oxygen Therapy, Continuous Positive Airway Pressure (CPAP) Oxygen Therapy, Invasive Mechanical Ventilation With Oxygen Therapy

2) By Surfactant Therapy: Natural Surfactants, Synthetic Surfactants, Combined Surfactant Therapy (Natural + Synthetic), Prophylactic Surfactant Therapy, Rescue Surfactant Therapy

What Are the Key Market Trends in the Neonatal Respiratory Distress Syndrome Treatment Industry?

In the neonatal respiratory distress syndrome treatment market, leading corporations are focusing on developing cutting-edge technology, such as nitric oxide generators, to improve oxygenation, reduce respiratory problems, and provide non-invasive therapies for newborns with hypoxic respiratory failure. A nitric oxide generator, as a medical instrument, generates and delivers nitric oxide gas which is usually employed to address respiratory complications by increasing oxygenation and alleviating pulmonary hypertension, mainly in newborns and seriously ill individuals. For instance, Beyond Air Inc., a medical device and biopharmaceutical corporation based in the US, achieved FDA approval for LungFit PH in June 2022. This novel nitric oxide generator is manufactured to treat term and near-term newborns with hypoxic respiratory failure, encompassing persistent pulmonary hypertension of the newborn (PPHN). The device uses Beyond Air’s proprietary Ionizer technology to produce nitric oxide from surrounding air on demand, ensuring an unlimited supply without concerns about dosage or flow. It employs a low-energy compressor to ionize nitrogen and oxygen, thereby curbing nitrogen dioxide (NO2) production, which is then safely removed through a smart filter.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/neonatal-respiratory-distress-syndrome-treatment-global-market-report

What Is the Regional Outlook for the Neonatal Respiratory Distress Syndrome Treatment Market?

North America was the largest region in the neonatal respiratory distress syndrome treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal respiratory distress syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20899

This Report Delivers Insight On:

1. How big is the neonatal respiratory distress syndrome treatment market, and how is it changing globally?

2. Who are the major companies in the neonatal respiratory distress syndrome treatment market, and how are they performing?

3. What are the key opportunities and risks in the neonatal respiratory distress syndrome treatment market right now?

4. Which products or customer segments are growing the most in the neonatal respiratory distress syndrome treatment market?

5. What factors are helping or slowing down the growth of the neonatal respiratory distress syndrome treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model